Your session is about to expire
← Back to Search
Procedure
Phototherapy Garments for Psoriasis
N/A
Recruiting
Led By Joseph Jorizzo, M.D.
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult participants ≥18 years of age
Participants who are diagnosed with mild-to-severe AA, PMLE, or psoriasis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights
Study Summary
This trial is looking at whether or not a new, more accessible phototherapy treatment is effective for psoriasis.
Who is the study for?
This trial is for adults over 18 living in the US with mild-to-severe Alopecia Areata, Polymorphous Light Eruption, or psoriasis. They must speak English well enough to understand the study requirements. People under 18, without these specific conditions, not living in the US, or using other phototherapy treatments cannot join.Check my eligibility
What is being tested?
The trial is testing Lumiton yarn products (sleeve, hat, shirt) designed to provide a form of light therapy for skin conditions like psoriasis and alopecia. The goal is to see if wearing these clothes can help improve disease severity by mimicking beneficial effects of UV light treatment.See study design
What are the potential side effects?
Since this trial involves clothing that emits light similar to phototherapy rather than drugs or invasive procedures, side effects may be minimal but could include skin irritation or sensitivity where the fabric touches.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have been diagnosed with AA, PMLE, or psoriasis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disease severity - PASI
Disease severity - SALT
Disease severity - photo
Trial Design
3Treatment groups
Active Control
Group I: PsoriasisActive Control1 Intervention
Psoriasis participants will be provided sleeves made from the Lumiton yarn to cover their arms. The participants will be instructed to wear the sleeves made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Group II: Alopecia AreataActive Control1 Intervention
Alopecia areata participants will be provided a hat made from the Lumiton yarn. The participants will be instructed to wear the hat made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Group III: Polymorphous Light EruptionActive Control1 Intervention
Polymorphous light eruption participants will be provided a shirt made from the Lumiton yarn. The participants will be instructed to wear the shirt made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,242 Previous Clinical Trials
1,004,252 Total Patients Enrolled
12 Trials studying Psoriasis
988 Patients Enrolled for Psoriasis
Joseph Jorizzo, M.D.Principal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently undergoing phototherapy treatment.I am not fluent in English.You have other health problems that could make it hard to understand the study results.I am under 18 years old.I do not have mild to severe alopecia areata, polymorphic light eruption, or psoriasis.I am 18 years old or older.I have been diagnosed with AA, PMLE, or psoriasis.
Research Study Groups:
This trial has the following groups:- Group 1: Psoriasis
- Group 2: Alopecia Areata
- Group 3: Polymorphous Light Eruption
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor accepting participants who are over thirty years of age?
"As specified by the regulations of this trial, individuals must be between 18 and 65 to qualify as participants."
Answered by AI
What is the total participant count of this clinical research endeavor?
"Affirmative. Clinical trials registry shows that this investigation, which was initially publicized on August 9th 2022, is still recruiting patients. 15 volunteers are required for the experiment to be conducted at one research site."
Answered by AI
What qualifications are necessary to partake in this research project?
"Fifteen candidates, aged between 18 and 65 with alopecia areata, who reside in the US and have a proficient understanding of English will be enrolled. Additionally, they must fit into one or more of the following categories: mild-to-severe AA, PMLE or psoriasis."
Answered by AI
Is recruitment still open for this research project?
"According to clinicaltrials.gov, this medical study is currently seeking out participants, with the first listing posted on August 9th 2022 and most recently edited on August 26th of that same year."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger